Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Pharma
FDA considers 'regulatory action' for bluebird's Skysona
The FDA is investigating reports of patients developing blood cancer after receiving bluebird bio’s Skysona and is considering regulatory action.
Kevin Dunleavy
Dec 2, 2024 11:22am
PTC wins FDA approval for brain-delivered gene therapy Kebilidi
Nov 14, 2024 11:31am
Sarepta's Elevidys blows sales expectations out of the water
Nov 7, 2024 3:43pm
Consumer groups urge FTC to block Novo Holdings' Catalent deal
Oct 18, 2024 10:20am
AstraZeneca-CSPC, Astellas and more—Fierce Pharma Asia
Oct 11, 2024 9:48am
Ferring cuts ribbon at new gene therapy manufacturing hub
Oct 3, 2024 12:07pm
